Drug
Dsp 5336
Dsp 5336: highest development phase Phase 1, developed by Sumitomo Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Sumitomo Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| DSP-5336 NCT07444268 | Phase 1 | Advanced Hematologic Malignancies |
Latest
No recent events.
Follow Dsp 5336 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.